Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Vertex Pharmaceuticals    VRTX

VERTEX PHARMACEUTICALS (VRTX)
Mes dernières consult.
Most popular
  Report  
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsofficial PublicationsSector newsTweets

Vertex Pharmaceuticals Incorporated : VRTX, OSTK, and GRPN added to Nasdaq Gainers Watch List at GSR

share with twitter share with LinkedIn share with facebook
share via e-mail
0
04/19/2013 | 05:40pm CEST

New York, NY -- (ACCESSWIRE) -- 04/19/2013 -- Growing Stock Report initiates a NASDAQ Gainers Weekly Watch List adding Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX), Overstock.com Inc. (NASDAQ:OSTK), Groupon, Inc. (NASDAQ:GRPN), BioScrip Inc. (NASDAQ:BIOS) and Catalyst Pharmaceutical Partners Inc. (NASDAQ:CPRX).

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) a company that engages in discovering, developing, manufacturing, and commercializing small molecule drugs for patients with serious diseases is currently up (+55.57%) on 13,455,455 shares traded after announcing statistically significant results from a phase 2 study for the treatment of cystic fibrosis. Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) is currently up (+134.49%) from its recent 52-week low which has prompted Growing Stock Report to add the stock to their NASDAQ Gainers Watch List.

To see what other Investors are saying about Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)

Click Here: http://www.growingstockreport.com/Survey.aspx?stock=VRTX&SubId=AW

Catalyst Pharmaceutical Partners Inc. (NASDAQ:CPRX) a development-stage specialty pharmaceutical company is currently up (+24.10%) on 1,789,829 shares traded after Coverage was initiated on Catalyst Pharmaceutical by Aegis Capital. Catalyst Pharmaceutical Partners Inc. (NASDAQ:CPRX) is currently up (+105.41%) from its recent 52-week low which has prompted Growing Stock Report to add the stock to their NASDAQ Gainers Watch List.

To see what other Investors are saying about Catalyst Pharmaceutical Partners Inc. (NASDAQ:CPRX)

Click Here: http://www.growingstockreport.com/Survey.aspx?stock=CPRX&SubId=AW

Also mentioned in Growing Stock Report's Nasdaq Gainers Watch List and Investor Poll was: Overstock.com Inc. (NASDAQ:OSTK), Groupon, Inc. (NASDAQ:GRPN), Catalyst Pharmaceutical Partners Inc. (NASDAQ:CPRX) and BioScrip Inc. (NASDAQ:BIOS).

To see what other Investors are saying about: OSTK, GRPN, CPRX and BIOS

Click Here: http://www.growingstockreport.com/PR.aspx?stock=OSTK-GRPN-CPRX-BIOS&SubID=AW

GrowingStockReport.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities.

Through a vast network of IR professionals GrowingStockReport.com is often aware of several large investor awareness campaigns being deployed.

Timing is important when trading Small Caps and Penny Stocks.

Simply sign up for free and start receiving exclusive alerts.

Subscribe Here: http://www.GrowingStockReport.com

Disclosure: GrowingStockReport.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit GrowingStockReport.com website, for complete risks and disclosures.

Contact Info:
Growing Stock Report
[email protected]


© Accesswire 2013
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on VERTEX PHARMACEUTICALS
05/18VERTEX PHARMACEUTICALS INC / MA : Entry into a Material Definitive Agreement, Su..
AQ
05/18ICER PANEL : Low value for Vertex CF drugs
AQ
05/17VERTEX PHARMACEUTICALS : EIP gets $20.5M to develop AD candidate
AQ
05/10CONCERT PHARMACEUTICALS : Reports First Quarter 2018 Financial Results
AQ
05/07VERTEX PHARMACEUTICALS : Awards $400,000 in Scholarships to People Living with C..
AQ
05/03VERTEX PHARMACEUTICALS : Announces VX-445 Phase 3 Trial Program, Positive Data o..
AQ
05/02VERTEX PHARMACEUTICALS : Reports First-Quarter 2018 Financial Results
AQ
05/02VERTEX PHARMACEUTICALS : Initiates Phase 3 Studies of VX-445, Tezacaftor and Iva..
AQ
05/01VERTEX PHARMACEUTICALS : Awards $400,000 in Scholarships to People Living with C..
BU
04/30VERTEX PHARMACEUTICALS : U.S. & U.K. payers want greater discounts on Orkambi
AQ
More news
News from SeekingAlpha
05/18Investors bullish on biotechs after Trump drug pricing speech 
05/17Avalara Files To Raise $150 Million In U.S. IPO 
05/11Trump speech on drug prices light on specifics 
05/11Trump plan on drug prices to be announced this afternoon 
05/09BIOTECH ANALYSIS CENTRAL PHARMA NEWS : Takeda's Acquisition Win, Ionis And Akcea.. 
Financials ($)
Sales 2018 2 804 M
EBIT 2018 885 M
Net income 2018 583 M
Finance 2018 2 561 M
Yield 2018 -
P/E ratio 2018 69,81
P/E ratio 2019 45,44
EV / Sales 2018 13,4x
EV / Sales 2019 10,7x
Capitalization 40 070 M
Chart VERTEX PHARMACEUTICALS
Duration : Period :
Vertex Pharmaceuticals Technical Analysis Chart | VRTX | US92532F1003 | 4-Traders
Technical analysis trends VERTEX PHARMACEUTICALS
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Income Statement Evolution
Consensus
 
Mean consensus OUTPERFORM
Number of Analysts 25
Average target price 191 $
Spread / Average Target 23%
EPS Revisions
Managers
NameTitle
Jeffrey M. Leiden Chairman, President & Chief Executive Officer
Ian F. Smith Chief Operating Officer & Executive Vice President
Thomas Graney Chief Financial Officer & Senior Vice President
David Matthew Altshuler Chief Scientific Officer & EVP-Global Research
Reshma Kewalramani Chief Medical Officer & Executive Vice President
Sector and Competitors
1st jan.Capitalization (M$)
VERTEX PHARMACEUTICALS4.24%40 070
GILEAD SCIENCES-5.60%88 444
REGENERON PHARMACEUTICALS-19.72%31 977
GENMAB23.23%12 291
BEIGENE LTD (ADR)97.71%10 130
BLUEBIRD BIO INC1.77%9 488